A Seminar on Market Access Strategies for the Pharmaceutical Industry Concludes Successfully; Organizers and Co-organizers Deepen International Perspectives

 

The seminar, "Market Access for the Pharmaceutical Industry," organized by the Taiwan Bio-Industry Development Association and co-organized by our firm, Ching Chen Law Firm, and CIPIC Consultants Co., Ltd., was successfully held on March 19, 2026. The event was conducted both online and in person.

 

The seminar, held at the National Biotechnology Research Park, attracted numerous professionals and practitioners from the biotechnology and pharmaceutical industries. With increasingly fierce competition in the global pharmaceutical market, "Market Access" has become a crucial issue for the successful launch and commercialization of drugs. This event focused on this core theme, providing the industry with the latest trends and strategic thinking.

 

Professor Eric Bouteiller was the keynote speaker. Combining years of research and practical experience in the pharmaceutical market access field, the presentation provided an in-depth analysis of the global pharmaceutical industry's development trends, policy environment, and challenges in market access strategies. It also shared insights on how companies can formulate effective entry strategies and response mechanisms in different markets. The content, combining theoretical depth with practical value, was unanimously praised by the attendees.

 

As a co-organizer of this event, our firm actively participated in the on-site exchanges, engaging in in-depth discussions with industry leaders on the relationship between intellectual property rights and pharmaceutical market access, further promoting cross-disciplinary professional integration.

 

Through this keynote speech and exchange, participants not only broadened their international perspectives but also gained a more comprehensive understanding of the key decisions in the pharmaceutical product development and market launch process. The event successfully facilitated knowledge exchange and experience sharing within the industry, providing important references for Taiwanese biotechnology and pharmaceutical companies in their global market strategy and development.

 

In the future, the organizers and our firm will continue to promote related professional exchange activities, working together to help the industry stay abreast of international developments and enhance its overall competitiveness.